Design Therapeutics, Inc. (DSGN) Financials

DSGN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 215.1 million 13.3 million
March 31, 2026 230.4 million 12.4 million
Dec. 31, 2025 226.2 million 13.7 million
Sept. 30, 2025 211.8 million 12.1 million

DSGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -15.5 million 3.9 million
March 31, 2026 -16.4 million 3.9 million
Dec. 31, 2025 -12.0 million 3.4 million
Sept. 30, 2025 -11.2 million 3.6 million

DSGN Net Income

No data available :(

DSGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 207.4 million - 2.0 million
March 31, 2026 222.8 million - 2.7 million
Dec. 31, 2025 219.8 million - 1.5 million
Sept. 30, 2025 206.0 million - 877000

DSGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 62.5 million
March 31, 2026 61.4 million
Dec. 31, 2025 57.3 million
Sept. 30, 2025 57.0 million

DSGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 21000 16.4 million 5.8 million -
March 31, 2026 - 14.4 million 5.3 million -
Dec. 31, 2025 34000 13.4 million 4.7 million -70000
Sept. 30, 2025 - 14.6 million 4.7 million 70000

DSGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 151000
March 31, 2026 - -
Dec. 31, 2025 - -14.7 million
Sept. 30, 2025 - 14.6 million

DSGN

Price: $14.83

52 week price:
3.95
17.25

Earnings Per Share: -1.20 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 301800

Market Capitalization: 914.9 million

Links: